Science Explorer Back to mapMap

Most cited papers from Méditerranée Infection Foundation

What are the most cited papers from Méditerranée Infection Foundation?

The most cited paper from Méditerranée Infection Foundation is "Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors" (Bertrand Routy et al., 2017), with 5,679 citations. Next come "The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade" (1,855) and "ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes" (1,554).

Showing 50 of 60 papers. Every paper with more than 264 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors Bertrand Routy et al. · Science 2 Nov 2017 5,679
2 The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade Bruno Coutard, Coralie Valle, Xavier Nicolas de Lamballerie et al. · Antiviral Research Open access 10 Feb 2020 1,855
3 ARG-ANNOT, a New Bioinformatic Tool To Discover Antibiotic Resistance Genes in Bacterial Genomes Sushim Kumar Gupta, Babu Roshan Padmanabhan, Seydina Mouhamadou Diene et al. · Antimicrobial Agents and Chemotherapy Open access 21 Oct 2013 1,554
4 Real estimates of mortality following COVID-19 infection David Baud, Xiaolong Qi, Karin Nielsen‐Saines et al. · The Lancet Infectious Diseases Open access 12 Mar 2020 1,362
5 New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? Christian Albert Devaux, Jean‐Marc Rolain, Philippe Colson et al. · International Journal of Antimicrobial Agents Open access 12 Mar 2020 1,128
6 The global threat of antimicrobial resistance: science for intervention Ignasi Roca et al. · New Microbes and New Infections Open access 16 Apr 2015 1,125
7 Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola et al. · medRxiv PreprintOpen access 20 Mar 2020 1,123
8 Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Philippe Colson, Jean‐Marc Rolain, Jean‐Christophe Lagier et al. · International Journal of Antimicrobial Agents Open access 4 Mar 2020 985
9 Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study Gilbert Habib et al. · European Heart Journal Open access953 authors 12 Aug 2019 920
10 Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards Bernard La Scola, Marion Le Bideau, Julien Andréani et al. · European Journal of Clinical Microbiology & Infectious Diseases Open access 27 Apr 2020 900
11 Culturing the human microbiota and culturomics Jean‐Christophe Lagier, Grégory Dubourg, Matthieu Million et al. · Nature Reviews Microbiology Review 24 Jun 2018 874
12 Minimum Information about an Uncultivated Virus Genome (MIUViG) Simon Roux et al. · Nature Biotechnology Open access 17 Dec 2018 824
13 The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies Laurence Zitvogel, Yuting Ma, Didier Raoult et al. · Science Open access 22 Mar 2018 792
14 Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study Philippe Gautret et al. · Travel Medicine and Infectious Disease Open access Mar 2020 791
15 Improved reference genome of Aedes aegypti informs arbovirus vector control Benjamin John Matthews et al. · Nature Open access 14 Nov 2018 695
16 Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths Paul Bastard et al. · Science Immunology Open access195 authors 10 Aug 2021 643
17 The role of whole genome sequencing in antimicrobial susceptibility testing of bacteria: report from the EUCAST Subcommittee M.J. Ellington et al. · Clinical Microbiology and Infection Open access 23 Nov 2016 608
18 Staphylococcus aureus Nasal Colonization: An Update on Mechanisms, Epidemiology, Risk Factors, and Subsequent Infections Adèle Sakr, Fabienne Brégeon, Jean‐Louis Mège et al. · Frontiers in Microbiology Open access 8 Oct 2018 581
19 Zika Virus Infection — After the Pandemic Didier Musso, Albert Icksang Ko, David Baud · New England Journal of Medicine Open access 4 Oct 2019 575
20 Of chloroquine and COVID-19 Franck Touret, Xavier Nicolas de Lamballerie · Antiviral Research Open access 6 Mar 2020 559
21 Association of COVID-19 inflammation with activation of the C5a–C5aR1 axis Julien Carvelli et al. · Nature Open access 29 Jul 2020 556
22 Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea Johan van Griensven et al. · New England Journal of Medicine Open access 6 Jan 2016 552
23 Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade Gladys Ferrere et al. · JCI Insight Open access 15 Dec 2020 531
24 ACE2 receptor polymorphism: Susceptibility to SARS-CoV-2, hypertension, multi-organ failure, and COVID-19 disease outcome Christian Albert Devaux, Jean‐Marc Rolain, Didier Raoult · Journal of Microbiology Immunology and Infection Open access 6 May 2020 493
25 Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France Matthieu Million et al. · Travel Medicine and Infectious Disease Open access May 2020 490
26 Chloroquine for the 2019 novel coronavirus SARS-CoV-2 Philippe Colson, Jean‐Marc Rolain, Didier Raoult · International Journal of Antimicrobial Agents Open access 15 Feb 2020 490
27 Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarction Bruno Lévy et al. · Journal of the American College of Cardiology Open access Jul 2018 482
28 18F-FDG brain PET hypometabolism in patients with long COVID Éric Guedj, Jacques‐Yves Campion, P. Dudouet et al. · European Journal of Nuclear Medicine and Molecular Imaging Open access 26 Jan 2021 473
29 Bacterial culture through selective and non-selective conditions: the evolution of culture media in clinical microbiology Muriel Bonnet, Jean‐Christophe Lagier, Didier Raoult et al. · New Microbes and New Infections Open access 2 Dec 2019 447
30 Gut microbiota signatures are associated with toxicity to combined CTLA-4 and PD-1 blockade Miles Cameron Andrews et al. · Nature Medicine Open access 8 Jul 2021 438
31 In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication Franck Touret, Magali Gilles, Karine Barral et al. · Scientific Reports Open access 4 Aug 2020 435
32 The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB Jeremiah Muhwa Chakaya, Eskild Petersen, Rebecca Nantanda et al. · International Journal of Infectious Diseases Open access 20 Mar 2022 430
33 Environmental transmission of Toxoplasma gondii: Oocysts in water, soil and food Karen Shapiro, Lillian Bahia-Oliveira, Brent R. Dixon et al. · Food and Waterborne Parasitology Open access Apr 2019 416
34 Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses Didier Raoult, Alimuddin I. Zumla, Franco Locatelli et al. · Cell Stress Open access 9 Mar 2020 411
35 Antibiotic discovery: history, methods and perspectives Guillaume André Durand, Didier Raoult, Grégory Dubourg · International Journal of Antimicrobial Agents Open access 23 Nov 2018 407
36 Taxonomy of the order Bunyavirales: update 2019 Abulikemu Abudurexiti et al. · Archives of Virology Open access103 authors 7 May 2019 406
37 Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage Aurélie Fluckiger et al. · Science Open access 21 Aug 2020 398
38 Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients Lisa Derosa et al. · European Urology Open access 3 May 2020 396
39 Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates Pauline Maisonnasse et al. · Nature Open access 22 Jul 2020 362
40 TRI-SCORE: a new risk score for in-hospital mortality prediction after isolated tricuspid valve surgery Julien Dreyfus et al. · European Heart Journal Open access 8 Sep 2021 361
41 Echo-Doppler estimation of left ventricular filling pressure: results of the multicentre EACVI Euro-Filling study Patrizio Lancellotti et al. · European Heart Journal - Cardiovascular Imaging 13 Mar 2017 353
42 Interference in Bacterial Quorum Sensing: A Biopharmaceutical Perspective Benjamin Rémy, Sonia Mion, Laure Plener et al. · Frontiers in Pharmacology Open access 7 Mar 2018 333
43 Amphioxus functional genomics and the origins of vertebrate gene regulation Ferdinand Marlétaz et al. · Nature Open access 20 Nov 2018 332
44 Arguments in favour of remdesivir for treating SARS-CoV-2 infections Wen‐Chien Ko, Jean‐Marc Rolain, Nan–Yao Lee et al. · International Journal of Antimicrobial Agents Open access 5 Mar 2020 329
45 HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe Emilie Karafillakis, Clarissa Simas, Caitlin Jarrett et al. · Human Vaccines & Immunotherapeutics ReviewOpen access 11 Jan 2019 326
46 In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect Julien Andréani, Marion Le Bideau, Isabelle Duflot et al. · Microbial Pathogenesis Open access 25 Apr 2020 319
47 Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study Masatoshi Kudo et al. · The Lancet 2025 315
48 Emergence and Spread of Basal Lineages of Yersinia pestis during the Neolithic Decline Nicolás Rascovan, Karl-Göran Sjögren, Kristian Kristiansen et al. · Cell Open access 6 Dec 2018 313
49 Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis Ashleigh Shannon, Barbara Selisko, Thi-Tuyet-Nhung Le et al. · Nature Communications Open access 17 Sep 2020 307
50 Isolated tricuspid valve surgery: impact of aetiology and clinical presentation on outcomes Julien Dreyfus et al. · European Heart Journal Open access 23 Jul 2020 304

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.